1. Search Result
Search Result
Results for "

129318-43-0

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-108685
    Alendronate sodium

    Alendronic acid monosodium salt

    Others Metabolic Disease
    Alendronate sodium is an orally active nitrogen-containing bisphosphonate. Alendronate sodium potently inhibits bone resorption. Alendronate sodium is used for the research of postmenopausal osteoporosis.
  • HY-11101
    Alendronate sodium hydrate

    Alendronate; MK 217; G-704650 Adronat

    Others Cancer
    Alendronate (sodium hydrate) is a farnesyl diphosphate synthase inhibitor with IC50 of 460 nM.
  • HY-B0631
    Alendronic acid

    Others Cancer
    Alendronic acid, a bisphosphonate, is a farnesyl diphosphate synthase (FDPS) inhibitor. Alendronic acid inhibits osteoclast-mediated bone resorption. Alendronic acid shows efficacy in postmenopausal osteoporosis, malignant hypercalcemia and Paget’s disease.